Abstract:BackgroundCerebral malaria (CM) is the most severe outcome of Plasmodium falciparum infection and a major cause of death in children from 2 to 4 years of age. A hospital based study in Ghana showed that P. falciparum induces eosinophilia and found a significantly higher serum level of eosinophil cationic protein (ECP) in CM patients than in uncomplicated malaria (UM) and severe malaria anemia (SA) patients. Single nucleotide polymorphisms (SNPs) have been described in the ECP encoding-gene (RNASE3) of which th… Show more
“…A severe pathology is attributed to the protein neurotoxicity, which causes cerebral malaria, a major cause of children ' s death at an early stage. The natural variant (Arg97Thr), which reduces the protein cytotoxicity ), seems to have been selected in the Ghana population exposed to malaria infection, as a mechanism to avoid the protein severe neurotoxic side effects (Adu et al , 2011 ). A similar scenario was reported for Schistosoma infection, a common helminth parasite in tropical areas.…”
Section: The Eosinophil Cationic Protein (Ecp) In Host Defencementioning
confidence: 78%
“…In fact, the proteolytic processing is used extensively in immunology cascade events. A local cleavage can release the active peptides in the infection area in the same manner as cecropin is released from cathelicidins expressed in neutrophils (Zanetti et al , 1995 ;Burton and Steel , 2009 ), lactoferricin is derived from the N-terminus (Krieg et al , 1998 ;Clark et al , 2003 ); Tyr33 nitration (Ulrich et al , 2008 ) Host defense against viral infections; chemotaxis for dendritic cells (Rosenberg , 2008a ) RNase 3 (tested against several Gram-negative and -positive species (Torrent et al , 2009b(Torrent et al , , 2011b Arg97/Thr (related to asthma propensity and disease-induced pathologies) (Eriksson et al, 2007a;Adu et al , 2011 ) Gly103Arg 3 potential N-glycosylation sites; 10 purifi ed variants of N-linked glycosylated forms (Eriksson et al , 2007b ); N-glycosylation processed upon secretion by activated eosinophils (Woschnagg et al , 2009 );…”
Antimicrobial RNases are small cationic proteins belonging to the vertebrate RNase A superfamily and endowed with a wide range of antipathogen activities. Vertebrate RNases, while sharing the active site architecture, are found to display a variety of noncatalytical biological properties, providing an excellent example of multitask proteins. The antibacterial activity of distant related RNases suggested that the family evolved from an ancestral host-defence function. The review provides a structural insight into antimicrobial RNases, taking as a reference the human RNase 3, also named eosinophil cationic protein (ECP). A particular high binding affi nity against bacterial wall structures mediates the protein action. In particular, the interaction with the lipopolysaccharides at the Gram-negative outer membrane correlates with the protein antimicrobial and specifi c cell agglutinating activity. Although a direct mechanical action at the bacteria wall seems to be suffi cient to trigger bacterial death, a potential intracellular target cannot be discarded. Indeed, the cationic clusters at the protein surface may serve both to interact with nucleic acids and cell surface heterosaccharides. Sequence determinants for ECP activity were screened by prediction tools, proteolysis and peptide synthesis. Docking results are complementing the structural analysis to delineate the protein anchoring sites for anionic targets of biological signifi cance.
“…A severe pathology is attributed to the protein neurotoxicity, which causes cerebral malaria, a major cause of children ' s death at an early stage. The natural variant (Arg97Thr), which reduces the protein cytotoxicity ), seems to have been selected in the Ghana population exposed to malaria infection, as a mechanism to avoid the protein severe neurotoxic side effects (Adu et al , 2011 ). A similar scenario was reported for Schistosoma infection, a common helminth parasite in tropical areas.…”
Section: The Eosinophil Cationic Protein (Ecp) In Host Defencementioning
confidence: 78%
“…In fact, the proteolytic processing is used extensively in immunology cascade events. A local cleavage can release the active peptides in the infection area in the same manner as cecropin is released from cathelicidins expressed in neutrophils (Zanetti et al , 1995 ;Burton and Steel , 2009 ), lactoferricin is derived from the N-terminus (Krieg et al , 1998 ;Clark et al , 2003 ); Tyr33 nitration (Ulrich et al , 2008 ) Host defense against viral infections; chemotaxis for dendritic cells (Rosenberg , 2008a ) RNase 3 (tested against several Gram-negative and -positive species (Torrent et al , 2009b(Torrent et al , , 2011b Arg97/Thr (related to asthma propensity and disease-induced pathologies) (Eriksson et al, 2007a;Adu et al , 2011 ) Gly103Arg 3 potential N-glycosylation sites; 10 purifi ed variants of N-linked glycosylated forms (Eriksson et al , 2007b ); N-glycosylation processed upon secretion by activated eosinophils (Woschnagg et al , 2009 );…”
Antimicrobial RNases are small cationic proteins belonging to the vertebrate RNase A superfamily and endowed with a wide range of antipathogen activities. Vertebrate RNases, while sharing the active site architecture, are found to display a variety of noncatalytical biological properties, providing an excellent example of multitask proteins. The antibacterial activity of distant related RNases suggested that the family evolved from an ancestral host-defence function. The review provides a structural insight into antimicrobial RNases, taking as a reference the human RNase 3, also named eosinophil cationic protein (ECP). A particular high binding affi nity against bacterial wall structures mediates the protein action. In particular, the interaction with the lipopolysaccharides at the Gram-negative outer membrane correlates with the protein antimicrobial and specifi c cell agglutinating activity. Although a direct mechanical action at the bacteria wall seems to be suffi cient to trigger bacterial death, a potential intracellular target cannot be discarded. Indeed, the cationic clusters at the protein surface may serve both to interact with nucleic acids and cell surface heterosaccharides. Sequence determinants for ECP activity were screened by prediction tools, proteolysis and peptide synthesis. Docking results are complementing the structural analysis to delineate the protein anchoring sites for anionic targets of biological signifi cance.
“…In addition, another study demonstrated that ECP can suppress the growth of Pf in in vitro [ 22 ]. Above findings led to several genetic studies of the RNASE 3 gene in African populations [ 19 , 20 ], which all showed an association between RNASE 3 polymorphisms (+ 371C > G and + 499G > C) and SM [ 19 , 20 ], further confirming its role in severity of the disease. The minor allele frequencies of + 371C > G and + 499G > C polymorphisms were more than 0.20 in African populations [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 90%
“…Similarly, among host genes, polymorphisms in intercellular adhesion molecule 1 (ICAM-1), cluster of differentiation 36 (CD36), tumor necrosis factor-alpha (TNF-α), Interferon-gamma (IFN-γ), interleukin-1β, complement receptor-1 (CR-1), ATP binding cassette subfamily B member 1 (ABCB1) and adenosine A2a receptor (ADORA2A) have linked to the development of SM [ 9 – 16 ]. Ribonuclease 3 ( RNASE 3 ), which encodes eosinophil cationic protein (ECP), an important protein produced by eosinophils during inflammation and infection [ 17 , 18 ], was found to increase susceptibility to SM [ 19 – 22 ]. Indeed, SM patients had higher ECP levels and hypereosinophilia compared to UM patients [ 21 ].…”
“…Furthermore, an in vitro study has demonstrated that ECP could inhibit P. falciparum growth in a dose-dependent manner (Waters et al, 1987). Based on the evidence that ECP might be important in the control of P. falciparum infection, but may also play a role in CM pathogenesis, Adu et al (2011) investigated the association between polymorphisms in RNASE3 and susceptibility to CM in a hospital-based malaria study involving CM, SA, and UM patients. During the analysis of the c.371G.C polymorphism [rs2073342; 434(G > C)], results showed that the 371G allele was associated with susceptibility to CM and forms part of a risk-associated haplotype GGA defined by the markers: rs2073342 (G-allele), rs2233860 (G-allele), and rs8019343 (Aallele), respectively.…”
The eosinophil cationic protein (ECP) is a small polypeptide that originates from activated eosinophil granulocytes. A wide range of stimuli has been shown to induce the secretion of ECP. The gene that encodes the human ECP is located on chromosome 14, and the protein shares the overall three-dimensional structure and the RNase active-site residues with other proteins in the RNase A superfamily. Several single-nucleotide polymorphisms in the human ECP gene have been currently described. ECP has many biological functions, including an immunoregulatory function, the regulation of fibroblast activity, and the induction of mucus secretion in the airway. Additionally, the protein is a potent cytotoxic molecule and has the capacity to kill mammalian and nonmammalian cells. The purpose of this article was to review the known biological and genetic characteristics of ECP that contribute to the understanding of this protein's role in the development and progression of a wide variety of diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.